General Information of the Compound
Compound ID
CP0502989
Compound Name
1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-2-phenylpyridazine-3,6-dione
    Show/Hide
Structure
Formula
C23H25ClN4O2
Molecular Weight
424.932
Canonical SMILES
Clc1cccc(c1)N1CCN(CCCn2n(-c3ccccc3)c(=O)ccc2=O)CC1
    Show/Hide
InChI
InChI=1S/C23H25ClN4O2/c24-19-6-4-9-21(18-19)26-16-14-25(15-17-26)12-5-13-27-22(29)10-11-23(30)28(27)20-7-2-1-3-8-20/h1-4,6-11,18H,5,12-17H2
    Show/Hide
InChIKey
JKAGFPNHDXRGJT-UHFFFAOYSA-N
Physicochemical Property
logP
2.8649
Rotatable Bonds
6
Heavy Atom Count
30
Polar Areas
50.48
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45482877
ChEMBL ID
CHEMBL575032
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 204.17 nM
   TI
   LI
   LO
   TS